Advertisement
News
Subscribe to MDT Magazine News

FDA Clears Abbott's i-STAT® 1 Wireless Point of Care Testing System

March 29, 2011 5:32 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., March 29, 2011 /- Abbott announced today it has received clearance from the U.S. Food and Drug Administration to begin marketing the i-STAT® 1 Wireless handheld, a new wireless version of the i-STAT® point of care testing system that is widely used in hospitals,...

TOPICS:

Cellceutix autism drug attracts CDA

March 29, 2011 4:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Beverly biotechnology firm Cellceutix Corp. has said its treatment for autism, KM-391, has prompted a Confidential Disclosure Agreement with an unnamed "multi-billion dollar pharmaceutical company."

Boston Scientific Announces Its ACC 2011 Schedule

March 29, 2011 4:36 am | by Boston Scientific | Comments

Clinical presentations to include 12-month data on PROMUS Elementâ„¢ Platinum Chromium Stent

TOPICS:
Advertisement

Pelvic arterial embolization for postpartum hemorrhage saves lives, preserves uterus

March 29, 2011 4:35 am | by EurekAlert | Comments

(Society of Interventional Radiology) Pelvic arterial embolization or PAE, a minimally invasive, life-saving therapy, is a safe and effective treatment for postpartum hemorrhage, say researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

TOPICS:

No scalpel: Minimally invasive breakthrough for men?s enlarged prostates improves symptoms

March 29, 2011 4:35 am | by EurekAlert | Comments

(Society of Interventional Radiology) A new interventional radiology treatment that blocks blood supply to men's enlarged prostate glands shows comparable clinical results to transurethral resection of the prostate (or TURP), considered the gold standard (or most common) treatment....

TOPICS:

Soladek Vitamin Solution: Unapproved Product May Contain Dangerously High Levels of Vitamins A and D

March 29, 2011 4:31 am | by U.S. Food & Drug Administration | Comments

Reports of consumers experiencing decreased renal function, elevated levels of calcium in the blood, fatigue, heart arrhythmia, vomiting, and diarrhea.

TOPICS:

Moderate sleep and less stress may help with weight loss

March 29, 2011 3:38 am | by EurekAlert | Comments

(Kaiser Permanente) If you want to increase your chances of losing weight, reduce your stress level and get adequate sleep. A new Kaiser Permanente study found that people trying to lose at least 10 pounds were more likely to reach that goal if they had lower stress levels and...

TOPICS:

Celerite Slimming Tea: Recall - Undeclared Drug Ingredient

March 29, 2011 3:38 am | by U.S. Food & Drug Administration | Comments

Product marketed as a dietary supplement contains sibutramine, which may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

Advertisement

Stray Energy Burns Become a "Hot Topic" in Recent Publications

March 29, 2011 3:37 am | by Bio-Medicine.Org | Comments

BOULDER, Colo., March 29, 2011 /- Encision Inc. (Pink Sheets: ECIA ) –- Stray energy burns and laparoscopic safety have become intensive topics of discussion in recent publications, most notably in the Supplement to Outpatient Surgery Magazine (March 2011).  The potential...

TOPICS:

Reportlinker Adds Endoscopy Devices Market to 2016 - Need For Therapeutic Endoscopy and Advancements in HD Endoscopy to Drive Flexible Endoscopes

March 29, 2011 3:37 am | by Bio-Medicine.Org | Comments

NEW YORK, March 29, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Endoscopy Devices Market to 2016 - Need For Therapeutic Endoscopy and Advancements in HD Endoscopy to Drive Flexible Endoscopes...

TOPICS:

Initiation of FLINT Announced by NIDDK: Study of Intercept Pharmaceuticals' Obeticholic Acid (INT-747) in NASH

March 29, 2011 3:35 am | by Bio-Medicine.Org | Comments

NEW YORK, March 29, 2011 /- Intercept Pharmaceuticals, Inc., has been informed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health that patient enrollment has started in a new clinical trial in patients with nonalcoholic...

TOPICS:

Reportlinker Adds Point of Care Diagnostic Testing World Markets

March 29, 2011 3:33 am | by Bio-Medicine.Org | Comments

NEW YORK, March 29, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Point of Care Diagnostic Testing World Markets http://www.reportlinker.com/p089474/Point-of-Care-Diagnostic-Testing-World-Markets.html Point of care testing (POCT)...

TOPICS:

Powdec announces breakthrough Gallium Nitride transistor design

March 29, 2011 2:37 am | by I-Micronews | Comments

Dramatically reduces power losses, increases break-down voltage, eliminates current collapse.

BioDrain Medical, Inc. Completes Installation of Its Streamwayâ„¢ Automated Surgical Fluid Disposal System in Minnesota Hospital

March 29, 2011 2:34 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, March 29, 2011 /- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR ), producer of the FDA cleared Streamway™ System for automated surgical fluid disposal, announced today that it has completed the installation of its patented Streamway™ System in a large Minnesota...

TOPICS:

Reportlinker Adds Orthopedics Markets

March 29, 2011 2:32 am | by Bio-Medicine.Org | Comments

NEW YORK, March 29, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Orthopedics Markets http://www.reportlinker.com/p0368861/Orthopedics-Markets.html Orthopedics is a medical specialty that deals with the diagnosis and treatment of...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading